Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
204
NCT00813826
Efficacy and Safety Study of SLC022 in Treating Pain Associated With Post Herpetic Neuralgia
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 2009
Completion: Nov 30, 2009